Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Jiuhe Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the development and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). Founded in 2003 and based in Nantong, Jiangsu Province, the company operates as a wholly-owned subsidiary of Haisco Pharmaceutical Group. The company is best known for its expertise in gastroenterology, particularly for its flagship product, Rabeprazole Sodium Enteric-coated Tablets, marketed under the brand name Jiuhe. Its manufacturing facilities are GMP-certified and equipped to produce high-quality small molecule therapeutics for the domestic market. As a key production base for Haisco, Nantong Jiuhe plays a vital role in the parent company's commercial strategy and supply chain management. The company focuses on maintaining rigorous quality standards while expanding its portfolio of digestive and cardiovascular treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Jiuhe Pharmaceutical.